Role of researches in improving a cancer care service and a direction for further improvement of medical science
https://doi.org/10.17650/1726-9776-2015-11-2-14-22
Abstract
This paper deals with the analysis of current trends in world cancer science and with a search for ways to intensify the development of Russian oncology. It summarizes the results of the development of cancer science in the last 10 years and formulates main problems and handicaps on the way of its further development in order to make reasoned decisions to reform the system and to create a development strategy for the next decade.
About the Authors
O. G. Sukonko
N. N. Aleksandrov National Cancer Center of Belarus; Lesnoy Agrotown, Minsk District 23040, Republic of Belarus
Russian Federation
Russian Federation
S. A. Krasny
N. N. Aleksandrov National Cancer Center of Belarus; Lesnoy Agrotown, Minsk District 23040, Republic of Belarus
Russian Federation
Russian Federation
References
1. Океанов А. Е., Моисеев П. И., Левин Л. Ф. Статистика онкологических заболеваний в Республике Беларусь, 2003–2012. Под ред. О. Г. Суконко. Минск: РНПЦ ОМР им. Н. Н. Александрова, 2013. 373 с. [Statistics of cancer diseases in the Republic of Belarus throughout 2003–2012. A. E. Okeanov, P. I. Moiseev, L.F. Levin. Edited by O.G. Sukonko. Minsk: N. N. Alexandrov Research and PracticalCentre of Oncology and Medical Radiology, 2013. 373 p. (In Russ.)].
2. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1192–308.
3. Красный С. А., Тарендь Д. Т., Суконко О. Г. и др. Первый опыт скрининга рака предстательной железы в Республике Беларусь. Cиб онкол журн 2013;3(57):66–9. [Krasny S.A., Tarend D.T., Sukonko O.G. et al. First experienceof prostate cancer screening in the Republic of Belarus. Sibirskiy onkologycheskiy jurnal = Siberian Journal of Oncology 2013; 3(57): 66–9. (In Russ.)].
4. Montorsi F., Wilson T. G., Rosen R. C. et al. Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 2012;62:368–81.
5. Смолякова Р. М., Матусевич В. А., Курчин В. П. и др. Молекулярно-генетическая оценка экспрессии гена ERCCI при немелкоклеточном раке легкого. Матлы респ. научно-практической конференции с международным участием «Актуальные вопросы диагностики и лечения онкологических заболеваний», Минск, 20 декабря 2013. С. 54. [Smolyakova R.M., Matusevich V.A.,Kurchin V.P. et al. Molecular and genetic evaluation of gene ERCCI expression at non-small cells lung cancer. Materials of Republican Research and Practical Conference with international participation “Relevant issues of oncologic diseases diagnostics and management”, Minsk, December 20, 2013. P. 54. (In Russ.)].
6. Moher D., Hopewell S., Schulz K. F. et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012;10:28–55.
7. Burock S., Meunier F., Lacombe D. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment? EurJ Cancer 2013;49:2777–83.
Review
For citations:
Sukonko O.G., Krasny S.A. Role of researches in improving a cancer care service and a direction for further improvement of medical science. Cancer Urology. 2015;11(2):14-22. (In Russ.) https://doi.org/10.17650/1726-9776-2015-11-2-14-22
Views:
1256
Email this article 